Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11712463 MRNA therapy for pompe disease

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Translate Bio
Translate Bio
0
Date Filed
July 7, 2021
0
Date of Patent
August 1, 2023
0
Patent Applicant
Translate Bio
Translate Bio
0
Patent Application Number
17369783
0
Patent Citations
‌
US Patent 8101741 Modified siRNA molecules and uses thereof
0
‌
US Patent 8188263 Modified siRNA molecules and uses thereof
0
‌
US Patent 8236943 Compositions and methods for silencing apolipoprotein B
0
‌
US Patent 8329070 Liposomal apparatus and manufacturing method
0
‌
US Patent 8513403 Modified siRNA molecules and uses thereof
0
‌
US Patent 8569256 Cationic lipids and methods for the delivery of therapeutic agents
0
‌
US Patent 8710200 Engineered nucleic acids encoding a modified erythropoietin and their expression
0
‌
US Patent 8822663 Engineered nucleic acids and methods of use thereof
0
‌
US Patent 8853377 mRNA for use in treatment of human genetic diseases
0
‌
US Patent 8883202 Lipid compositions
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11712463
0
Patent Primary Examiner
‌
Sean McGarry
0

Find more entities like US Patent 11712463 MRNA therapy for pompe disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.